WallStSmart

Brookfield Asset Management Ltd. (BAM)vsCrescent Capital BDC Inc (CCAP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Brookfield Asset Management Ltd. generates 3568% more annual revenue ($5.74B vs $156.40M). BAM leads profitability with a 48.9% profit margin vs -2.0%. CCAP appears more attractively valued with a PEG of 0.89. BAM earns a higher WallStSmart Score of 77/100 (B+).

BAM

Strong Buy

77

out of 100

Grade: B+

Growth: 8.7Profit: 8.0Value: 5.7Quality: 4.0
Piotroski: 2/9Altman Z: 1.97

CCAP

Buy

51

out of 100

Grade: C-

Growth: 4.7Profit: 5.0Value: 6.0Quality: 4.0
Piotroski: 5/9Altman Z: 0.58

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BAM5 strengths · Avg: 9.4/10
Profit MarginProfitability
48.9%10/10

Keeps 49 of every $100 in revenue as profit

Operating MarginProfitability
68.7%10/10

Strong operational efficiency at 68.7%

Revenue GrowthGrowth
60.8%10/10

Revenue surging 60.8% year-over-year

Market CapQuality
$75.49B9/10

Large-cap with strong market position

EPS GrowthGrowth
47.4%8/10

Earnings expanding 47.4% YoY

CCAP3 strengths · Avg: 9.3/10
Price/BookValuation
0.6x10/10

Reasonable price relative to book value

Operating MarginProfitability
78.4%10/10

Strong operational efficiency at 78.4%

PEG RatioValuation
0.898/10

Growing faster than its price suggests

Areas to Watch

BAM4 concerns · Avg: 3.8/10
P/E RatioValuation
27.2x4/10

Moderate valuation

Price/BookValuation
10.1x4/10

Trading at 10.1x book value

Altman Z-ScoreHealth
1.974/10

Grey zone — moderate risk

Return on EquityProfitability
6.0%3/10

ROE of 6.0% — below average capital efficiency

CCAP4 concerns · Avg: 2.5/10
Market CapQuality
$365.51M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.413/10

Elevated debt levels

Return on EquityProfitability
-0.5%2/10

ROE of -0.5% — below average capital efficiency

Revenue GrowthGrowth
-15.5%2/10

Revenue declined 15.5%

Comparative Analysis Report

WallStSmart Research

Bull Case : BAM

The strongest argument for BAM centers on Profit Margin, Operating Margin, Revenue Growth. Profitability is solid with margins at 48.9% and operating margin at 68.7%. Revenue growth of 60.8% demonstrates continued momentum.

Bull Case : CCAP

The strongest argument for CCAP centers on Price/Book, Operating Margin, PEG Ratio. PEG of 0.89 suggests the stock is reasonably priced for its growth.

Bear Case : BAM

The primary concerns for BAM are P/E Ratio, Price/Book, Altman Z-Score. Debt-to-equity of 5.69 is elevated, increasing financial risk.

Bear Case : CCAP

The primary concerns for CCAP are Market Cap, Debt/Equity, Return on Equity.

Key Dynamics to Monitor

BAM profiles as a growth stock while CCAP is a turnaround play — different risk/reward profiles.

BAM carries more volatility with a beta of 1.26 — expect wider price swings.

BAM is growing revenue faster at 60.8% — sustainability is the question.

BAM generates stronger free cash flow (393M), providing more financial flexibility.

Bottom Line

BAM scores higher overall (77/100 vs 51/100), backed by strong 48.9% margins and 60.8% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Brookfield Asset Management Ltd.

FINANCIAL SERVICES · ASSET MANAGEMENT · USA

Brookfield Asset Management is a leading global alternative asset manager and one of the largest investors in real assets.

Visit Website →

Crescent Capital BDC Inc

FINANCIAL SERVICES · ASSET MANAGEMENT · USA

Crescent Capital BDC, Inc. is a business development company. The company is headquartered in United States.

Visit Website →

Want to dig deeper into these stocks?